Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × neratinib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasms 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1

Interventions

Specimen Handling 7 Biopsy 6 fludarabine 3 ruxolitinib 2 decitabine and cedazuridine drug combination 2 Tacrolimus 2 Injections 2 Decitabine 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 venetoclax 1 veliparib 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 axatilimab 1 Topotecan 1 Thiotepa 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡